BioSpace News Archive

LeMaitre Vascular, Inc. announced that management will be participating in four upcoming investor conferences in March.

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced the appointment of Jim Douglas as the Company’s new Chief Financial Officer (CFO) effective March 1, 2022.

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), announced today that XPOVIO®(selinexor) has been granted approval from the Health Sciences Authority (HSA) in Singapore for three indications.

Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol Myers Squibb”), with its wholly-owned subsidiary Celgene Corporation (“Celgene”) (collectively, the “Offerors”), announced the early participation results, as of 5:00 p.m. (New York City time) on March 1, 2022 (the “Early Tender Deadline”), of the previously announced 22 separate offers to purchase for cash notes issued by the Offerors listed in the tables below.

GRIP Molecular Technologies, Inc., an early-stage diagnostic company, announced that it has been accepted into Blue Knight, a joint initiative between Johnson and Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority.